Janney Montgomery Scott’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Janney Montgomery Scott's PPH Position: Q3 2026 in Review
Janney Montgomery Scott sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2026, closing a stake of 1,892 shares — an estimated $207K sold.
Janney Montgomery Scott first reported a position in PPH in Q3 2018 and held it in 16 quarters. The position peaked at $493K in Q3 2024. 155 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- Janney Montgomery Scott reported no remaining VanEck Pharmaceutical ETF position as of Q3 2026 after selling out during the quarter.
- Janney Montgomery Scott sold 1,892 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $207K.
- Janney Montgomery Scott first reported a position in VanEck Pharmaceutical ETF in Q3 2018 and held it in 16 quarters.
- Janney Montgomery Scott's VanEck Pharmaceutical ETF position peaked at $493K in Q3 2024.
- 155 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.